An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer

Abstract Background Debates exist on the treatment decision of the stage II/III colorectal cancer (CRC) due to the insufficiency of the current TNM stage‐based risk stratification system. Epithelial–mesenchymal transition (EMT) and tumor microenvironment (TME) have both been linked to CRC progressio...

Descripció completa

Dades bibliogràfiques

Autors principals:	Du Cai, Wei Wang, Min‐Er Zhong, Dejun Fan, Xuanhui Liu, Cheng‐Hang Li, Ze‐Ping Huang, Qiqi Zhu, Min‐Yi Lv, Chuling Hu, Xin Duan, Xiao‐Jian Wu, Feng Gao
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2023-04-01
Col·lecció:	Cancer Medicine
Matèries:	colorectal cancer epithelial–mesenchymal transition immune prognosis stroma
Accés en línia:	https://doi.org/10.1002/cam4.5534
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!